- Home
- MAPS vs ZNTL Comparison
MAPS vs ZNTL Comparison
Compare MAPS & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAPS
- ZNTL
- Stock Information
- Founded
- MAPS 2008
- ZNTL 2014
- Country
- MAPS United States
- ZNTL United States
- Employees
- MAPS N/A
- ZNTL N/A
- Industry
- MAPS Computer Software: Prepackaged Software
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- MAPS Technology
- ZNTL Health Care
- Exchange
- MAPS Nasdaq
- ZNTL Nasdaq
- Market Cap
- MAPS 94.2M
- ZNTL 105.8M
- IPO Year
- MAPS N/A
- ZNTL 2020
- Fundamental
- Price
- MAPS $1.18
- ZNTL $1.59
- Analyst Decision
- MAPS Strong Buy
- ZNTL Buy
- Analyst Count
- MAPS 1
- ZNTL 7
- Target Price
- MAPS $2.61
- ZNTL $8.46
- AVG Volume (30 Days)
- MAPS 1.4M
- ZNTL 597.7K
- Earning Date
- MAPS 08-07-2025
- ZNTL 08-06-2025
- Dividend Yield
- MAPS N/A
- ZNTL N/A
- EPS Growth
- MAPS N/A
- ZNTL N/A
- EPS
- MAPS 0.09
- ZNTL N/A
- Revenue
- MAPS $183,681,000.00
- ZNTL $26,865,000.00
- Revenue This Year
- MAPS N/A
- ZNTL N/A
- Revenue Next Year
- MAPS $10.22
- ZNTL N/A
- P/E Ratio
- MAPS $13.64
- ZNTL N/A
- Revenue Growth
- MAPS 0.13
- ZNTL N/A
- 52 Week Low
- MAPS $0.70
- ZNTL $1.01
- 52 Week High
- MAPS $1.65
- ZNTL $5.44
- Technical
- Relative Strength Index (RSI)
- MAPS 60.85
- ZNTL 65.16
- Support Level
- MAPS $1.11
- ZNTL $1.36
- Resistance Level
- MAPS $1.30
- ZNTL $1.55
- Average True Range (ATR)
- MAPS 0.09
- ZNTL 0.09
- MACD
- MAPS 0.04
- ZNTL 0.01
- Stochastic Oscillator
- MAPS 72.73
- ZNTL 71.91
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.